BioWorld

July 10, 2003

View Archived Issues

Front-Running DD3PCA3 Gene Faced Off PSA Test Of Prostate Carcinoma In First-Shot Urology Clinic Line-Up

Read More

Correction

Read More

Other News To Note

Read More

Appointments And Advancements

Read More

U.S. Patent Disclosures

Read More

PDL Sells $250M In Notes To Pay Down Old Debt, Fund Expansion

Protein Design Labs Inc. is planning to replace old debt with new after gaining $250 million through the sale of convertible subordinated notes in a private placement. (BioWorld Today) Read More

Neurion's CNS Technologies Attracting Pharma Attention

Read More